Literature DB >> 28574146

Niemann-Pick type C as a cause of progressive intellectual and neurological deterioration in childhood.

Anne Marie Winstone1, Lesley Ann Stellitano1, Christopher Michael Verity1.   

Abstract

AIM: To describe the cases of Niemann-Pick type C (NP-C) disease in a United Kingdom epidemiological study of progressive intellectual and neurological deterioration in childhood.
METHOD: Paediatricians notified cases via the British Paediatric Surveillance Unit between 1997 and 2015.
RESULTS: Fifty-three NP-C patients were identified: 29 females, 24 males. Fifteen cases had a systemic presentation (neonatal jaundice and/or hepatosplenomegaly). Thirty-eight had a neurological onset, the commonest presenting symptom being gait disturbance/ataxia (29 cases, 76%). Forty-nine cases eventually had neurological problems, the commonest were school/cognitive difficulties (40, 82%), seizures (33, 67%), dysphagia (20, 41%), dysarthria (18, 37%), cataplexy (17, 35%), and visual deterioration (8, 16%); their commonest abnormal physical signs were vertical supranuclear gaze palsy (35, 71%), hypotonia (19, 39%) and hepatosplenomegaly (19, 39%). The median diagnostic delay in the 38 neurological onset cases was 3 years (range 0.3-12.8). Confirmatory investigations included filipin staining of skin fibroblasts (42 cases), bone marrow examination in 30 (the last in 2011), and increasingly DNA studies, mutations in NP-C1 being found in 20 cases.
INTERPRETATION: NP-C should be considered in children with progressive neurological deterioration. Subtle neurological problems combined with a history of prolonged neonatal jaundice and/or hepatosplenomegaly may provide early evidence of the disease.
© 2017 Mac Keith Press.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28574146     DOI: 10.1111/dmcn.13476

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  4 in total

1.  Neurodevelopmental Characterization of Young Children Diagnosed with Niemann-Pick Disease, Type C1.

Authors:  Audrey Thurm; Colby Chlebowski; Lisa Joseph; Cristan Farmer; Dee Adedipe; Madison Weiss; Edythe Wiggs; Nicole Farhat; Simona Bianconi; Elizabeth Berry-Kravis; Forbes D Porter
Journal:  J Dev Behav Pediatr       Date:  2020 Jun/Jul       Impact factor: 2.988

2.  Expanded access with intravenous hydroxypropyl-β-cyclodextrin to treat children and young adults with Niemann-Pick disease type C1: a case report analysis.

Authors:  Caroline Hastings; Camilo Vieira; Benny Liu; Cyrus Bascon; Claire Gao; Raymond Y Wang; Alicia Casey; Sharon Hrynkow
Journal:  Orphanet J Rare Dis       Date:  2019-10-21       Impact factor: 4.123

3.  Surveillance for variant CJD: should more children with neurodegenerative diseases have autopsies?

Authors:  Christopher Verity; Anne Marie Winstone; Robert Will; Alison Powell; Peter Baxter; Carlos de Sousa; Paul Gissen; Manju Kurian; John Livingston; Robert McFarland; Suvankar Pal; Michael Pike; Richard Robinson; Evangeline Wassmer; Sameer Zuberi
Journal:  Arch Dis Child       Date:  2018-10-18       Impact factor: 3.791

Review 4.  Recommendations for patient screening in ultra-rare inherited metabolic diseases: what have we learned from Niemann-Pick disease type C?

Authors:  María-Jesús Sobrido; Peter Bauer; Tom de Koning; Thomas Klopstock; Yann Nadjar; Marc C Patterson; Matthis Synofzik; Chris J Hendriksz
Journal:  Orphanet J Rare Dis       Date:  2019-01-21       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.